Resbiomed Technologies

Resbiomed Technologies OOD is a Bulgaria-based biotechnology company specializing in the development and commercialization of innovative regenerative medicine solutions and ophthalmological devices. The company focuses on extracellular-matrix (ECM)-based biomaterials and biologics derived from human tissues, particularly placenta-based collagen-rich products intended for tissue repair and regenerative applications. Founded by Dr. Alexander Angelov, Resbiomed Technologies leverages advanced bioprocessing to create standardized biological materials for diverse clinical uses, including the treatment of corneal diseases and general wound healing. In 2025, the company entered into a strategic collaboration with Pluri Inc. to utilize their PluriCDMO division for the scalable manufacturing and process development of its placenta-derived biomaterials. Resbiomed Technologies operates within a broader healthcare network that includes a clinical research organization and specialist eye clinics, positioning it at the intersection of medical device innovation and advanced biological therapies.